Related Experiment Video
Updated: Dec 2, 2025

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
Concurring hypertrophic cardiomyopathy and takotsubo cardiomyopathy: Assessment and management
Mohammed Abozenah1, Anis John Kadado1, Ahmad Aljamal2
1Department of Internal Medicine, UMMS-Baystate Medical Center, Springfield, MA, USA.
Insights
Takotsubo cardiomyopathy (TCM) co-occurring with hypertrophic cardiomyopathy (HOCM) is rare but manageable. This study suggests TCM may predispose HOCM patients to left ventricular outflow tract obstruction even after recovery.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Takotsubo cardiomyopathy (TCM) prevalence is increasing.
- Co-occurrence of TCM with hypertrophic cardiomyopathy (HOCM) is uncommon.
- HOCM significantly complicates TCM by increasing hemodynamic compromise risk.
Purpose of the Study:
- To analyze the clinical characteristics, management, and outcomes of patients with co-occurring TCM and HOCM.
- To investigate the potential for TCM to induce or exacerbate left ventricular outflow tract (LVOT) obstruction in HOCM.
Main Methods:
- Retrospective analysis of patient cases with co-occurring TCM and HOCM.
- Review of clinical data, including demographics, presentation, management strategies, and outcomes.
- Assessment of LVOT gradient changes before, during, and after TCM resolution.
Main Results:
- Patient demographics were similar to typical TCM cases.
- Management mirrored standalone TCM, with increased use of inotropic agents and mechanical support.
- Outcomes were generally favorable during hospitalization and at follow-up.
- Approximately 50% of patients newly diagnosed with HOCM developed persistent LVOT obstruction post-TCM.
Conclusions:
- TCM in the context of HOCM presents unique challenges but appears manageable with favorable outcomes.
- A significant proportion of HOCM patients experienced persistent LVOT obstruction after TCM resolution.
- Further research is needed to understand if TCM can predispose to LVOT obstruction in HOCM.
Abstract:
The prevalence of takotsubo cardiomyopathy (TCM) has been on the rise, but co-occurrence with hypertrophic cardiomyopathy (HOCM) remains rare. Although presenting patient demographics were similar to those in TCM, the potential for hemodynamic compromise was significantly compounded by the presence of underlying HOCM. Management was similar to standalone TCM, although use of inotropic agents and mechanical support appears to be more prevalent. Despite the increased potential for complications and the paucity of data regarding management, outcomes appear to be mostly favorable in both the hospitalization period and at follow-up. Interestingly, despite a new diagnosis of HOCM in about half the cases described, which signifies no significant left ventricular outflow tract (LVOT) gradient prior to TCM, half of those patients had a persistently elevated LVOT gradient after resolution of TCM. This poses a question of whether or not TCM can predispose to LVOT obstruction in HOCM patients even after its resolution.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy VI: Nursing Management
Myocarditis IV: Nursing Management

